Characterization of Adeno-Associated Virus Capsid Proteins Using Hydrophilic Interaction Chromatography Coupled with Mass Spectrometry
Authors:
Open Access
- 1 September 2020
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 189, 113481
Abstract
No abstract availableKeywords
Funding Information
- Regeneron Pharmaceuticals
This publication has 29 references indexed in Scilit:
- Clinical Considerations for Capsid Choice in the Development of Liver-Targeted AAV-Based Gene TransferMolecular Therapy - Methods & Clinical Development, 2019
- Post‐translational modifications in capsid proteins of recombinant adeno‐associated virus (AAV) 1‐rh10 serotypesThe FEBS Journal, 2019
- Adeno-associated virus vector as a platform for gene therapy deliveryNature Reviews Drug Discovery, 2019
- Deamidation of Amino Acids on the Surface of Adeno-Associated Virus Capsids Leads to Charge Heterogeneity and Altered Vector FunctionMolecular Therapy, 2018
- Adeno-Associated Virus (AAV) as a Vector for Gene TherapyBioDrugs, 2017
- AAV-Mediated Gene Therapy for Research and Therapeutic PurposesAnnual Review of Virology, 2014
- Capsid Antibodies to Different Adeno-Associated Virus Serotypes Bind Common RegionsJournal of Virology, 2013
- Tyrosine-phosphorylation of AAV2 vectors and its consequences on viral intracellular trafficking and transgene expressionVirology, 2008
- Insect Cells as a Factory to Produce Adeno-Associated Virus Type 2 VectorsHuman Gene Therapy, 2002
- Adenovirus-associated Virus Structural Protein Sequence HomologyJournal of General Virology, 1979